incidence and severity of treatment emergent adverse events (TEAEs) and serious adverse events (SAEs);Number of participants with Clinically significant abnormality findings;The incidence and severity of injection site reactions (ISRs)

incidence and severity of treatment emergent adverse events (TEAEs) and serious adverse events (SAEs);Number of participants with Clinically significant abnormality findings;The incidence and severity of injection site reactions (ISRs)